De novo use of generic tacrolimus in liver transplantation - a single center experience with one-yr follow-up.

@article{Dannhorn2014DeNU,
  title={De novo use of generic tacrolimus in liver transplantation - a single center experience with one-yr follow-up.},
  author={Emily H Dannhorn and M Cheung and S{\'o}nia Rodrigues and Hassie Cooper and Douglas Thorburn and David W. Patch and Andrew K. Burroughs and James H. O'Beirne},
  journal={Clinical transplantation},
  year={2014},
  volume={28 12},
  pages={1349-57}
}
UNLABELLED Use of generic tacrolimus in liver transplantation (LT) could result in cost savings. Generic tacrolimus has been shown to be bioequivalent to innovator tacrolimus in healthy volunteers and renal transplant patients. There are limited data on the de novo use of generic tacrolimus in LT. This study aimed to determine whether the de novo use of generic tacrolimus (Adoport, Sandoz,UK) was associated with differences in outcomes, safety, and cost compared with innovator tacrolimus… CONTINUE READING

Citations

Publications citing this paper.

References

Publications referenced by this paper.
Showing 1-10 of 16 references

Tacrolimus trough 1356 Dannhorn et al. levels, rejection and renal impairment in liver transplantation: a systematic review and meta-analysis

  • M RODR IGUEZ-PER ALVAREZ, G GERMANI, T DARIUS, J LERUT, E TSOCHATZIS, AK. BURROUGHS
  • Am J Transplant
  • 2012
2 Excerpts

Similar Papers

Loading similar papers…